Status | Study |
Available |
Study Name: Single Patient Expanded Access to Ganitumab for Metastatic Ewing Sarcoma Condition: Ewing Sarcoma Date: 2017-01-20 Interventions: Drug: Ganitumab The patient will receive ganitumab, 18 mg/kg/dose intravenously every 2 weeks until clin |
Recruiting |
Study Name: First-line Treatment of Ewing Tumours With Primary Extrapulmonary Dissemination in Patients From 2 to 50 Years Condition: Ewing Sarcoma Family of Tumors Date: 2016-12-06 Interventions: Drug: VDC-IE x2 |
Recruiting |
Study Name: Pbi-shRNA™ EWS/FLI1 Type 1 LPX in Subjects With Advanced Ewing's Sarcoma Condition: Ewing's Sarcoma Date: 2016-04-04 Interventions: Biological: pbi-shRNA™ EWS/FLI1 Type 1 LPX Other Name: pbi-shRNA™ EWS/FLI1 Type 1 Lipoplex |
Recruiting |
Study Name: Protocol for the Treatment of Metastatic Ewing Sarcoma Condition: Ewing's Sarcoma (ES) Date: 2016-03-23 Interventions: Drug: TEMIRI Window therapy fr |
Recruiting |
Study Name: TK216 in Patients With Relapsed or Refractory Ewing Sarcoma Condition: Sarcoma, Ewing Date: 2016-01-12 Interventions: Drug: TK216 Inhibitor of protein-protein interactions of EWS-FLI1 fusion protein |
Recruiting |
Study Name: A Two-part Phase IIb Trial of Vigil in Ewing's Sarcoma Condition: Ewing's Sarcoma Date: 2015-07-28 Interventions: Biological: Vigil Vigil 1.0 x |
Completed |
Study Name: Eurosarc Trial of Linsitinib in Advanced Ewing Sarcoma Condition: Relapsed Ewing Sarcoma Refractory Ewing S Date: 2014-08-06 Interventions: Drug: Linsitinib Other Names: OSI-906 ASP7487 |
Recruiting |
Study Name: ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP Inhibitor, Niraparib and Temozolomide or Irinotecan in Patients With Previously Treated, Incurable Ewing Sarcoma Condition: Ewing Sarcoma Date: 2014-01-21 Interventions: Drug: niraparib Drug: Temozolomide |
Withdrawn |
Study Name: A Phase I Study to Examine the Toxicity of Allogeneic Stem Cell Transplantation for Relapsed or Therapy Refractory Ewing Sarcoma Condition: Ewing Sarcoma Date: 2013-10-21 Interventions: Biological: allogeneic stem cell transplantation |
Recruiting |
Study Name: Phase I Study of Olaprib and Temozolomide for Ewings Sarcoma Condition: Ewing Sarcoma Date: 2013-05-08 Interventions: Drug: Olaparib Tablets to be t |